NASDAQ: SCLXScilex Holding Co Stock
$0.90+0.00 (+0%)
Updated Apr 19, 2024
SCLX Price
$0.90
Fair Value Price
N/A
Market Cap
$149.24M
52 Week Low
$0.80
52 Week High
$12.54
P/E
-0.7x
P/B
-0.86x
P/S
5.69x
PEG
N/A
Dividend Yield
N/A
Revenue
$46.74M
Earnings
-$114.33M
Gross Margin
66.5%
Operating Margin
-242.28%
Profit Margin
-244.6%
Debt to Equity
-1.59
Operating Cash Flow
-$21M
Beta
0.11
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SCLX Overview
Vickers Vantage Corporation I is a "blank check" company formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar combinations with one or more businesses. The company has not publicly identified its target sectors. The company was incorporated in 2020 and is headquartered in Singapore.
Zen Score
–
Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SCLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SCLX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SCLX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SCLX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SCLX due diligence checks available for Premium users.
Be the first to know about important SCLX news, forecast changes, insider trades & much more!
SCLX News
Valuation
SCLX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.7x
Industry
152.97x
Market
40.51x
SCLX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.86x
Industry
5.79x
SCLX's financial health
Profit margin
Revenue
$13.5M
Net Income
-$21.4M
Profit Margin
-159%
SCLX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SCLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$101.3M
Liabilities
$274.2M
Debt to equity
-1.59
SCLX's short-term liabilities ($250.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SCLX's short-term assets ($46.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SCLX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SCLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.4M
Investing
-$167.0k
Financing
$8.3M
SCLX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SCLX vs General Drug Manufacturer Stocks
Scilex Holding Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.